Apply to trial NCT06494878

A few quick questions so the study team can decide if you might be a fit.

RecruitingPhase 3Drug trial

The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity

The goal of the PARTUM trial is to determine if taking low-dose aspirin daily for 6 weeks after delivery is similar (non-inferior) to usual care low-molecular-weight heparin injections to prevent venous thromboembolism (VTE: blood clots in the legs or lungs) for postpartum individuals with VTE risk factors.

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening